Clinical significance of Her2 pathological expression in breast and gastric cancer patients
10.3969/j.issn.1000-484X.2016.06.019
- VernacularTitle:Her2在乳腺癌和胃癌中表达的临床意义
- Author:
Zhenyu YAN
;
Chunyang MAI
;
Peng GAO
;
Bo SU
;
Shixuan WANG
- Publication Type:Journal Article
- Keywords:
Breast cancer;
Stomach cancer;
Her2;
Pathological features
- From:
Chinese Journal of Immunology
2016;32(6):858-862
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the clinical significance of Her2 pathological expression in the breast and gastric cancer patients for providing a reference for cancer prevention. Methods: Selected surgical resection specimens of 60 diagnosed in advanced gastric cancer and 60 diagnosed with advanced breast cancer from March 2009 to May 2014 in our hospital,all specimens were given the Her2 pathological expression of immunohistochemical analysis and investigation the clinical and pathological data. Results: The Her2 positive expression rates in the breast cancer and gastric cancer specimens were 40. 0% and 36. 7%,respectively that compared to no significant difference (P>0. 05). The Her2 expression was not related to the cancer patient’s age,histological type,and there were sig-nificantly correlated to the TNM stage and lymph node metastasis ( P<0. 05 ) . Spearman correlation analysis showed that Her2 expression in the breast cancer and gastric cancer were significant positive correlation to the Survivin, Bcl-2 expression ( P<0. 05 ) . Conclusion:Breast cancer and gastric cancer patients have shown high pathological expression of Her2,and are related to the TNM stage and lymph node metastasis, it may be through inhibited the apoptosis regulating proteins involved in the pathogenesis and metastasis of tumors.
